Skip to main content
  • Login
Home

User menu

Mega menu

  • EASL.eu
  • Resources

    Resources

    • EASL Resources
      • All Resources
      • Basic Techniques in Experimental Hepatology at a Glance
      • Clinical Practice Guidelines
      • Congress Resources
      • COVID-19 Resources
      • EASL Molecular Tumour Boards
      • EASL Genetic Grand Round
      • EASL Policy Dialogues
      • EASL Quiz
      • ePosters
      • EASL DeepDive
      • EASL Journal Club
      • Nurses and AHPs
      • Online Courses
      • On-demand Webinars
      • Podcasts
      • Slide Decks
      • Webcasts
      • Webinars Calendar
    • EASL-Related Resources
      • EHC On-demand Webinar
      • ERN Rare-Liver On-demand Webinars
      • Baveno VII - Consensus Workshop
      • Baveno VII - Pediatric Research Workshop
    • Industry Resources
      • All Resources
      • Industry Symposia - EASL Monothematic Conference 2023
      • Industry Symposia - EASL Congress
      • Industry Symposia - EASL Liver Cancer Summit
      • Industry Symposia - EASL SLD Summit
      • GSK Resources
    • Patient Resources
      • All Resources
      • COVID-19 Resources
      • Documents
      • ePosters
      • Infographics
      • Patient Guidelines
      • Podcasts
      • Slide Decks
      • Takeaways
      • Webcasts
  • EASL Studio
  • EASL Campus Connect
    • My Community
    • Explore Community
      • EASL Community Feed
      • All Topics
      • Community FAQ's
    • Create
  • Our Sponsors

EASL Community Feed

Get the latest news from the EASL Community

Newest topics

Hepatitis C Point of Care Testing
Gavin Hooper-Newton · 6 Feb
Welcome to EASL Campus Connect!
Elinam Gayi · 20 Jun
All topics

  • Gavin Hooper-Newton posted

    1 year ago

  • Daniza Contreras commented on EASL Studio S5 E10: Why should d…

    1 year ago
    EASL Studio S5 E10: Why should diabetologists care about the liver?

    EASL Studio S5 E10: Why should diabetologists care about the liver?

    Description In this episode, participants tackle the relationship between metabolic dysfunction-associated steatotic liver diseases (MASLD) and type 2 diabetes (T2D), exploring their prevalence and the potential for more aggressive outcomes. Experts weigh in on the pressing questions of whether non-invasive test thresholds shoul...
    Total amount of likes 1
    Total amount of comments 1
    Read more about EASL Studio S5 E10: Why should diabetologists care about the liver?
    Log in to post comments
    Daniza Contreras
    Daniza Contreras • 1 year ago

    Great

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • ABU SALEH MD SADEQUL ISLAM posted

    1 year ago

  • Robert Gish commented on Role of lymphatics in liver dise…

    1 year ago

  • Robert Gish commented on Arterial diseases affecting the…

    1 year ago

  • Kalyan vijay kumar bandaru commented on Reducing the burden of alcohol-r…

    1 year ago
    Reducing the burden of alcohol-related liver disease (ARLD)

    Reducing the burden of alcohol-related liver disease (ARLD)

    ARLD is responsible for nearly 40,000 deaths in Europe every year and alcohol consumption is directly correlated with liver disease mortality in most EU countries. It is largely a ‘silent’ illness, in 75% of cases, it is not identified until the patient is in the emergency room, with heavy drinkers at exponentially higher risk of...
    Total amount of likes 0
    Total amount of comments 1
    Read more about Reducing the burden of alcohol-related liver disease (ARLD)
    Log in to post comments
    Kalyan vijay kumar bandaru
    Kalyan vijay k… • 1 year ago

    Great

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Laura Daguerre commented on EASL Studio S5 E1: What is reall…

    1 year ago
    EASL Studio S5 E1: What is really new in the EASL CPG on ACLF?

    EASL Studio S5 E1: What is really new in the EASL CPG on ACLF?

    Description This #EASLStudio JHEP Live discusses the newly released EASL Clinical Practice Guidelines on Acute-on-chronic liver failure (ACLF). In particular: ICU admission criteria for patients with ACLF Treatment of infection and antibiotic selection Liver support Liver transplantation for ACLF: Sarcopenia and...
    Total amount of likes 2
    Total amount of comments 2
    Read more about EASL Studio S5 E1: What is really new in the EASL CPG on ACLF?
    Log in to post comments
    Laura Daguerre • 1 year ago

    Some of these questions were answered during the live discussion.
    If you have any additional questions or comments for our expert panel, please use the comment box :)
    EASL Office

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous
    Laura Daguerre • 1 year ago

    Questions from the audience during the live discussion:
    - Should transplant candidacy influence the decision to bring ACLF patients into ICU for monitoring? Thanks
    - Should antifungal be routinely given in ACLF patients admitting to ICU?

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • MARIA TERESA RIZO ROBLES commented on Hepatorenal syndrome – acute kid…

    1 year ago

  • Wolfgang Hein commented on EASL Policy Dialogues S2 E4: Wor…

    1 year ago
    EASL Policy Dialogues S2 E4: World Hepatitis Day – Spotlight on Hepatitis D

    EASL Policy Dialogues S2 E4: World Hepatitis Day – Spotlight on Hepatitis D

    Description This episode focuses on Hepatitis D (HDV), which is less common than hepatitis B or C but is a serious disease that often affects underprivileged and vulnerable populations. HDV has long been neglected and even though it is a highly aggressive viral hepatitis which can rapidly progress to cirrhosis and liver can...
    Total amount of likes 0
    Total amount of comments 2
    Read more about EASL Policy Dialogues S2 E4: World Hepatitis Day – Spotlight on Hepatitis D
    Log in to post comments
    Wolfgang Hein
    Wolfgang Hein • 1 year ago

    Thank you for the interesting content. Will there be a transcript.

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous
    Maraika Black
    Maraika Black • 1 year ago

    Dear Wolfgang,
    Thank you for your comment and feedback. We typically do not post transcripts; however, if you would like one, please send me an email at maraika.black@easloffice.eu and I would be happy to provide you one.
    Have a good day.

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Jules Levin commented on Finding undiagnosed hepatitis C…

    1 year ago

  • Iván Mauricio Villamil Morales posted

    1 year ago

  • Elinam Gayi created a topic in EASL Education

    1 year ago

    Welcome to EASL Campus Connect!

    Created on
    20 Jun 2023 •
    by
    Elinam Gayi
    Total amount of likes 3
    Total amount of comments 0
    Read more about Welcome to EASL Campus Connect!

  • Elinam Gayi commented on Liver cancer risk after HCV cure…

    2 years ago

  • Yu Jun Wong commented on Liver cancer risk after HCV cure…

    2 years ago

  • Elinam Gayi commented on Liver cancer risk after HCV cure…

    2 years ago

  • YU JUN WONG commented on Prognostic performance of 7 biom…

    3 years ago

  • Sharat Varma commented on Prognostic performance of 7 biom…

    3 years ago

  • Mattias Mandorfer commented on Prognostic performance of 7 biom…

    3 years ago

  • Mattias Mandorfer commented on Prognostic performance of 7 biom…

    3 years ago

  • Elinam Gayi commented on Prognostic performance of 7 biom…

    3 years ago

    • Pagination

    • Previous page ‹‹
    • Next page ››

Community Stream

Easl Community FeedMy Feed
Browse Stream
EASL.EU Home
Home of Hepatology
7 rue Daubin
1203 Geneva
Switzerland

Follow us:

Sign up to EASL News

©2019 - EASL. All Rights Reserved. Powered by Enovation.

Footer menu

  • Content Access policy
  • Privacy Policy
  • Cookie Policy